You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2011 or most recent year available
Part (ii) All outpatient clients by primary drug and frequency of use (%)
| Primary drug | Not used in the past month/occasional | Once a week or less | 2–6 times per week | Daily | Frequency known (n) | Frequency unknown | |
|---|---|---|---|---|---|---|---|
| Opioids | 16.3 | 9.5 | 14.5 | 59.7 | 90820 | 13105 | |
| Cocaine | 21.7 | 24.1 | 30.9 | 23.3 | 35868 | 8565 | |
| Stimulants | 19.7 | 25.4 | 34.3 | 20.6 | 11491 | 975 | |
| Cannabis | 15.5 | 14.5 | 22.4 | 47.6 | 65659 | 9250 |
Notes:
Percentages are of clients whose frequency of use is known (n)
Only countries reporting data related to primary drug have been included.
For information relative to the countries included, please see Table TDI-7
See also Table TDI-111 for distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2012 — TDI table — outpatient treatment centres.